Minnie Baylor-Henry - 08 Feb 2023 Form 4 Insider Report for Paratek Pharmaceuticals, Inc. (PRTK)

Role: Director
Signature: /s/ William M. Haskel, Attorney-in-Fact for Minnie Baylor-Henry
Issuer symbol: PRTK
Transactions as of: 08 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 09 Feb 2023, 20:04:00 UTC
Previous filing: 13 Oct 2023
Next filing: 15 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRTK	Common Stock	Award	$0	+20,000	+51%	$0.000000	59,200	08 Feb 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the one-year anniversary of February 8, 2023, subject to the Reporting Person's continued service with the Issuer through the vesting date.

Content

Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the one-year anniversary of February 8, 2023, subject to the Reporting Person's continued service with the Issuer through the vesting date.